Seattle top stories

Bio Roundup: Coronavirus Concerns, Sarepta's CRL, Eye Drug OK'd & More

Bio Roundup: Coronavirus Concerns, Sarepta's CRL, Eye Drug OK'd & More

36 minutes ago   |   Xconomy

Company news slowed somewhat this week, perhaps as some took the federal Martin Luther King Jr. Day holiday away from the office and others recovered from back-to-back meetings...
Read more ...

Q&A With Eric Seaborg: Science Writer, Author, and Outdoorsman

Q&A With Eric Seaborg: Science Writer, Author, and Outdoorsman

6 hours ago   |   News Center

Eric Seaborg Eric Seaborg, a writer and author, outdoorsman and environmentalist, has a love for hiking that he shared with his father, the late chemist and Nobel laureate...
Read more ...

Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

11 hours ago   |   Xconomy

Epizyme won accelerated FDA approval Thursday for a drug developed to treat the rare cancer epithelioid sarcoma. The regulatory decision for the Epizyme drug, tazemetostat...
Read more ...

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

22 hours ago   |   Xconomy

MedImmune, AstraZeneca's biologics division, is no more. The pharmaceutical giant announced last year that the name would be retired as part of a research and development...
Read more ...

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

1 day ago   |   Xconomy

Safety concerns stymied Sarepta Therapeutics' attempt to win FDA approval last August for golodirsen , its second Duchenne muscular dystrophy drug. But an appeal of the...
Read more ...

InnovationXLab Biomanufacturing Summit Aims to Push Scientific Frontiers and Boost Bioeconomy

1 day ago   |   News Center

Next week, Lawrence Berkeley National Laboratory is hosting the Innovation X Lab Biomanufacturing Summit: An exclusive event aimed at showcasing how U.S. industry can leverage...
Read more ...

CEOs of Women's Health Companies Fight to Open Investment Floodgates

CEOs of Women's Health Companies Fight to Open Investment Floodgates

2 days ago   |   Xconomy

Talking about sex with potential investors? For EvoFem Biosciences CEO Saundra Pelletier, it's the first item on the docket. Her company recently submitted Amphora, a...
Read more ...

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

2 days ago   |   Xconomy

CRISPR gene editing offers the potential to selectively edit the genetic mutations causing inherited diseases, but Emendo Biotherapeutics CEO David Baram contends it's not...
Read more ...

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

2 days ago   |   Xconomy

The first treatment for a rare disease that causes eye bulging and double vision received an FDA nod on Tuesday, weeks ahead of the agency's March 8 deadline to review the...
Read more ...

Trending News on Crop Biotech in 2019

2 days ago   |   ISAAA

We summarized the top 10 most trending Crop Biotech Update news shared on social media to give you a glimpse of crop biotech happenings in 2019. Read it on ISAAA blog and make...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Bio Roundup: Coronavirus Concerns, Sarepta's CRL, Eye Drug OK'd & More

Bio Roundup: Coronavirus Concerns, Sarepta's CRL, Eye Drug OK'd & More

Company news slowed somewhat this week, perhaps as some took the federal Martin Luther King Jr. Day holiday away from the office and others recovered from back-to-back meetings... Read more ...

Q&A With Eric Seaborg: Science Writer, Author, and Outdoorsman

Q&A With Eric Seaborg: Science Writer, Author, and Outdoorsman

Eric Seaborg Eric Seaborg, a writer and author, outdoorsman and environmentalist, has a love for hiking that he shared with his father, the late chemist and Nobel laureate... Read more ...

Project to Rapidly Sequence Maize Pangenome Delivers Publicly Available Resource

Project to Rapidly Sequence Maize Pangenome Delivers Publicly Available Resource

Matt Hufford, associate professor at Iowa State University, helped produce a 26-line maize pangenome assembly collection Maize researchers have been rejoicing over a New Year's... Read more ...

Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

Epizyme won accelerated FDA approval Thursday for a drug developed to treat the rare cancer epithelioid sarcoma. The regulatory decision for the Epizyme drug, tazemetostat... Read more ...

The Wuhan Coronavirus Inspires a Look Back at the Discovery of Viruses

The Wuhan Coronavirus Inspires a Look Back at the Discovery of Viruses

I'm astonished at the speed with which geneticists and epidemiologists are zeroing in on the Wuhan coronavirus. Nomenclature is still up in the air. The first name, “2019-nCoV”... Read more ...

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

MedImmune, AstraZeneca's biologics division, is no more. The pharmaceutical giant announced last year that the name would be retired as part of a research and development... Read more ...

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

Safety concerns stymied Sarepta Therapeutics' attempt to win FDA approval last August for golodirsen , its second Duchenne muscular dystrophy drug. But an appeal of the... Read more ...

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

The first treatment for a rare disease that causes eye bulging and double vision received an FDA nod on Tuesday, weeks ahead of the agency's March 8 deadline to review the... Read more ...

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

CRISPR gene editing offers the potential to selectively edit the genetic mutations causing inherited diseases, but Emendo Biotherapeutics CEO David Baram contends it's not... Read more ...

CEOs of Women's Health Companies Fight to Open Investment Floodgates

CEOs of Women's Health Companies Fight to Open Investment Floodgates

Talking about sex with potential investors? For EvoFem Biosciences CEO Saundra Pelletier, it's the first item on the docket. Her company recently submitted Amphora, a... Read more ...